Skip to main content

Table 3 Comparisons among pulmonologist and non-pulmonologist physicians, according to progression assessment of disease.

From: Management and attitudes about IPF (Idiopathic Pulmonary Fibrosis) among physicians from Latin America

Progression assesment

Pulmonologist

 

Yes

n = 91 (29.7%)

No

n = 215 (70.3%)

 

Total

 
 

n

%

n

%

OR (CI 95%)

n

%

p value*

Dyspnea Scale

60

65.9

135

62.8

1.15 (0.69–1.92)

195

63.7

0.601

FVC lowering

75

82.4

115

53.5

4.08 (2.23–7.45)

190

62.1

0.000

DLCO lowering

50

54.9

26

12.1

8.87 (4.95–15.86)

76

24.8

0.000

CT

51

56.0

73

34.0

2.48 (1.50–4.09)

124

40.5

0.000

Exacerbation

28

30.8

65

30.2

1.03 (0.60–1.75)

93

30.4

0.926

6MWT

49

53.8

38

17.7

5.43 (3.16–9.33)

87

28.4

0.000

patient’s feedback

22

24.2

19

8.8

3.29 (1.68–6.44)

41

13.4

0.000

  1. *Chi square test